Valuation: Omnicell, Inc.

Market Cap 1.47B 1.28B 1.21B 1.1B 2.06B 141B 2.07B 14.5B 5.6B 71.72B 5.52B 5.4B 231B P/E 2026 *
32.8x
P/E 2027 * 31.8x
Enterprise Value 1.47B 1.28B 1.21B 1.1B 2.06B 141B 2.07B 14.5B 5.6B 71.72B 5.52B 5.4B 231B EV / Sales 2026 *
1.19x
EV / Sales 2027 * 1.14x
Free-Float
76.4%
Yield 2026 *
-
Yield 2027 * -
1 day-1.20%
1 week-1.71%
Current month-8.33%
1 month-10.40%
3 months-17.46%
6 months-5.29%
Current year-28.85%
1 week 32.04
Extreme 32.04
33.63
1 month 32.04
Extreme 32.04
36.55
Current year 31.75
Extreme 31.75
55
1 year 29.06
Extreme 29.06
55
3 years 22.66
Extreme 22.66
55.74
5 years 22.66
Extreme 22.66
187.28
10 years 22.66
Extreme 22.66
187.28
Manager TitleAgeSince
Chief Executive Officer 68 01/10/2002
Director of Finance/CFO 56 15/09/2025
President 50 01/07/2026
Director TitleAgeSince
Chairman 68 01/09/1992
Director/Board Member 70 01/01/2013
Director/Board Member 70 01/01/2014
Date Insider Type Main position Quantity % Market Cap. Importance
17/8/26 Sell

Chairperson

-3,083 0.0068%
15/8/26 Tax

Chief Executive Officer

-12,350 0.0272%
15/8/26 Tax

Chief Administrative Officer

-4,025 0.0089%
Change 5-day change 1-year change 3-year change Capi.($)
-1.20%-1.71%+1.35%-40.15% 1.47B
-1.34%-0.83%-6.76%+24.99% 42.13B
+0.21%+3.18%-43.25%+139.10% 12.59B
-3.98%+1.19%-7.54%+103.80% 5.65B
+2.38%+1.74%+56.25% - 4.41B
+0.12%+9.03% - - 2.2B
+1.06%-1.40%-38.24% - 1.03B
-1.18%-2.15%+13.35%+151.76% 991M
+3.94%+3.26%+37.09%+48.64% 913M
+2.00%+10.87%+9.68%-60.98% 800M
Average +0.20%+1.28%+2.44%+52.45% 7.22B
Weighted average by Cap. -0.86%+0.51%-8.66%+53.88%

Financials

2026 *2027 *
Net sales 1.24B 1.08B 1.02B 925M 1.73B 119B 1.74B 12.2B 4.71B 60.34B 4.65B 4.54B 194B 1.29B 1.12B 1.06B 963M 1.8B 124B 1.81B 12.71B 4.9B 62.85B 4.84B 4.73B 202B
Net income 45.27M 39.48M 37.28M 33.85M 63.42M 4.34B 63.69M 447M 172M 2.21B 170M 166M 7.11B 47.37M 41.3M 39M 35.42M 66.35M 4.55B 66.63M 467M 180M 2.31B 178M 174M 7.44B
Net Debt - -
Logo Omnicell, Inc.
Omnicell, Inc. is a healthcare technology provider focused on autonomous medication management, by unifying automation and AI-enabled intelligence, optimized by expert services, to drive clinical and business outcomes that are helping to improve efficiency and enhance patient safety for healthcare facilities. The Company is focused on helping its customers define and deliver a medication management strategy designed for pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. It provides a range of points of care medication and supplies dispensing systems, including automated systems and offers advanced automation solutions, including robotics designed to automate work, streamline workflows, and reduce human error. It provides central pharmacy automation solutions for both medication dispensing and IV compounding and provides patient engagement solutions.
Employees
3,485
Date Price Change Volume
18/09/26 US$32.23 -1.20% 937,250
17/09/26 US$32.62 +0.59% 394,292
16/09/26 US$32.43 -0.61% 439,351
15/09/26 US$32.63 -2.63% 642,618
14/09/26 US$33.51 +2.20% 395,750
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
32.23USD
Average target price
57.86USD
Spread / Average Target
+79.51%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. OMCL Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!